Regen BioPharma Inc (RGBP)

[cvinvestor]

Not much chance of .01 either. Even if RGBP doubled it's current OS from 124M to 250M OS shares by selling shares at .025/share, the company would then have $3.15M in cash and the dilution would only bring PPS value from .13 to .06 on paper. If RGBP had $3M in cash with 1 FDA approved product for trials and another scheduled for Q2 approval with yet another promising pipeline product at NIH/NCATs research, how long do you think it would stay around .06?

No, we are 1 Q away from closing down the pipe of highly discounted shares and the more of those shares are sold in Q1, the more cash on hand at least RGBP should have which in turn gives greater stability to the company as far as completing testing and moving product forward. I don't think we go to the moon in Q1 unless an unforeseen event of positive magnitude occurs regarding NCATS testing for NR2F6 compounds, but sounds like the schedule for that is anticipated to occur later.